Coming Soon

This webinar will provide a practical framework for the recognition and assessment of drug-induced movement disorders (also known as extrapyramidal symptoms) associated with antipsychotic and other dopamine-modifying therapies.

In this webinar, participants will review the pathophysiology and clinical presentation of common drug-induced movement disorder subtypes—including acute dystonia, akathisia, drug-induced parkinsonism, and tardive dyskinesia. Following this webinar on January 20, 2026 at 12 PT, the speakers will host an interactive workshop to practice what was learned in this webinar. This includes applying assessment tools, detecting and monitoring, case discussions and using validated rating scales.

Over the course of both Part 1 and Part 2, learners will strengthen their ability to identify, document, and communicate drug-induced movement disorder findings to optimize patient care and medication safety.